Aptinyx Stock Predictions

Healthcare > Biotechnology

Buy APTX

*Your capital is at risk

$0.0960

+0 (+0%)

At Close: Mar 28, 2024

Currently predicting for Mon, 15 Jun 2026

APTX Live board

Community Bull/Bear

Target Next close

Join the APTX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

APTX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For APTX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

APTX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT APTINYX INC

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also deve...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	13.43%	Jun 05
TPR $140.47	4.95%	Jun 04
LITE $905.00	1.83%	Jun 01
RUN $12.83	0.468%	May 06
GLBE $31.61	3.54%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by